Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

• Status: Completed
• Trial end date: 2015-12-22
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the safety and efficacy of administration of eszopiclone for 4 weeks in insomnia patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eisai Co., Ltd.
• Treatments: Eszopiclone

Criteria

Inclusion Criteria:

1. Insomnia participants who did not take eszopiclone before assessment

2. Participants who receive assessment by using sleep questionaries